Reports
Reports
Sale
The global brain monitoring market size was valued at USD 5.4 billion in 2023. It is expected to grow at a CAGR of 6.6% during the forecast period of 2024-2032 and attain a value of USD 9.6 billion by 2032. The market is driven by the increasing prevalence of neurological disorders and growing emphasis on mental health and wellness across the globe.
Report Attribute | Key Statistics |
Base Year | 2023 |
Forecast Years | 2024-2032 |
Historical Years | 2017-2023 |
Market Size in 2023 | USD 5.4 billion |
Market Forecast in 2032 | USD 9.6 billion |
Market Growth Rate (2024-2032) | 6.6% |
Technological Innovations
The development of sophisticated brain monitoring devices, such as portable EEG machines, wearable brain monitoring devices, and advanced imaging technologies, has greatly enhanced the ability to diagnose and monitor neurological conditions in real-time. These innovations offer improved accuracy, ease of use, and patient comfort, which, in turn, drive their adoption in clinical settings, boosting the brain monitoring market value.
Rising Prevalence of Neurological Disorders
There is a global increase in the incidence of neurological disorders such as epilepsy, Alzheimer's disease, Parkinson's disease, and stroke. This rise necessitates early diagnosis and continuous monitoring of patients, fueling the demand for brain monitoring devices and technologies.
Aging Population
The world is experiencing a significant increase in the elderly population, which is more prone to neurological disorders. This demographic shift is prompting healthcare systems and caregivers to focus more on monitoring and managing the health conditions associated with aging, including cognitive impairments and neurodegenerative diseases.
Growing Awareness and Healthcare Expenditure
There is an increasing awareness among the general population about the importance of early diagnosis and treatment of neurological conditions. Coupled with rising healthcare expenditure both by governments and private organisations, this awareness is driving the brain monitoring market demand.
Healthcare Infrastructure Expansion
Improvements and investments in healthcare infrastructure, especially in emerging economies, have made advanced medical technologies more accessible. Better healthcare facilities equipped with state-of-the-art brain monitoring tools can provide enhanced patient care, contributing to the market's growth.
The market is segmented based on various criteria to address the diverse needs of the healthcare sector and to cater to different patient requirements. These segments help in understanding the market dynamics, enabling targeted innovations, and facilitating effective marketing strategies. The primary segmentation of the brain monitoring market includes product type, application, modality, end-user, accessories, procedures, and geography. Each of these segments plays a crucial role in defining the market landscape and influencing development and growth strategies.
Market Breakup by Product Types
The global brain monitoring market is segmented based on various product types, each catering to different diagnostic and therapeutic needs within neurology. This segmentation facilitates targeted analysis and development efforts, addressing diverse medical requirements and enhancing patient care.
Among the product type, magnetoencephalography (MEG) systems, though less common, provide high-resolution brain activity mapping without direct contact with the scalp, offering unique advantages for certain research and clinical applications.
Electroencephalographs (EEG) are widely used for monitoring electrical activity in the brain, pivotal for diagnosing epilepsy, sleep disorders, and other neurological conditions. Cerebral oximeters, leveraging near-infrared spectroscopy, offer non-invasive monitoring of brain oxygenation levels, critical in surgeries and critical care to prevent hypoxic damage.
Functional magnetic resonance imaging (fMRI) stands out for its ability to measure brain activity by detecting changes associated with blood flow, crucial for understanding brain function and planning surgeries. Intracranial pressure monitoring devices are vital for patients with severe head injury or diseases like hydrocephalus, directly measuring the pressure inside the skull to guide treatment.
Each of these segments contribute uniquely to the market, with EEGs and cerebral oximeters widely adopted for their versatility and non-invasiveness, having a substantial brain monitoring market share. Meanwhile, advanced imaging technologies like fMRI and innovative monitoring solutions like MEG, though more specialized, are expected to influence the market by addressing complex clinical needs and enhancing neurological research.
Intracranial pressure monitors, given their critical role in emergency and neurosurgical care, are indispensable in specific patient populations. As the market evolves, technological advancements and increasing awareness of neurological conditions are anticipated to drive the brain monitoring market demand across all product segments, highlighting the importance of diversified and innovative brain monitoring solutions in improving patient outcomes.
Market Breakup by Application
The market is intricately segmented based on application, catering to a wide range of neurological conditions, each with its unique diagnostic and therapeutic requirements.
Parkinson’s disease segment involves the use of brain monitoring technologies for early detection, monitoring disease progression, and managing treatment efficacy. Given the increasing global prevalence of Parkinson's disease and the need for precise monitoring of motor symptoms and medication adjustments, this segment plays a crucial role in enhancing patient care and quality of life.
Traumatic brain injury (TBI) segment focuses on monitoring to assess the extent of injury, guide treatment decisions, and monitor recovery. The critical nature of timely and accurate diagnosis in improving outcomes for TBI patients underscores the importance of this segment in emergency care and rehabilitation settings.
Epilepsy is another significant application area, where continuous or long-term monitoring with EEG and other brain monitoring technologies is essential for diagnosing different types of seizures, guiding treatment plans, and assessing surgery outcomes. The rising prevalence of the condition fuels brain monitoring market growth. While dementia, including Alzheimer’s disease, requires sophisticated monitoring technologies to understand disease progression, evaluate treatments, and assist in research towards finding a cure. As the global population ages, the impact of this segment is expected to grow, highlighting the need for advanced diagnostic and monitoring tools.
Sleep disorders segment utilizes brain monitoring for diagnosing conditions such as sleep apnea, insomnia, and narcolepsy. The increasing recognition of sleep quality's impact on overall health has elevated the importance of this segment, driving demand for sleep monitoring technologies.
Each application segment is poised to influence the brain monitoring market size significantly in the forecast period. With the growing prevalence of neurological disorders, technological advancements, and increasing awareness of these conditions, the demand for specific and effective brain monitoring solutions across all these areas is expected to rise. Innovations tailored to the unique demands of each condition, coupled with the global healthcare system's emphasis on precision medicine, are set to drive the expansion of the market.
Market Breakup by Modality
The brain monitoring market segmentation, based on modality types, includes fixed, portable, and wearable devices, each offering unique advantages and catering to different user needs within healthcare and research settings.
Fixed brain monitoring devices are typically large, stationary machines found in hospitals or clinical settings, such as traditional MRI and CT scanners, and standard EEG systems. These devices are crucial for in-depth diagnostic procedures and continuous monitoring in critical care situations. Their high precision and reliability make them indispensable in diagnosing and managing severe neurological conditions, ensuring this segment remains vital to the overall market.
Portable brain monitoring devices have transformed the landscape of neurological care by enabling diagnostics and monitoring outside traditional clinical environments. These include compact versions of EEGs and cerebral oximeters that can be easily moved to patient bedsides or used in remote locations, enhancing accessibility to brain monitoring solutions. The flexibility and convenience offered by portable devices is expected to impact the brain monitoring market demand in the forecast period.
Wearable brain monitoring devices represent the forefront of innovation in the field, incorporating the latest technology to monitor brain activity in real-time while allowing patients to maintain mobility. These devices range from advanced EEG caps to devices designed for long-term monitoring of neurological conditions in everyday settings. The wearable segment is expected to substantially influence the market in the forecast period, driven by the growing demand for continuous, non-invasive monitoring solutions that support patients' lifestyles and improve disease management outside hospital settings.
Each modality type contributes differently to the market, with fixed devices providing foundational support in clinical diagnostics, portable devices expanding access to care, and wearable technologies pushing the boundaries of how and where brain monitoring can be utilized. The evolving healthcare landscape, with its increasing focus on patient-centric care, telehealth, and remote monitoring, is poised to further elevate the demand for portable and wearable devices, underscoring their potential to revolutionize brain monitoring market in the coming years.
Market Breakup by Accessories
The market can also be segmented based on accessories, with sensors and electrodes being pivotal components that significantly impact its dynamics and growth potential.
Sensors in brain monitoring devices are critical for detecting and measuring various physiological parameters. These can include electrical activity, oxygen levels, blood flow, and intracranial pressure, among others. The advancements in sensor technology have led to the development of more sensitive, accurate, and less invasive sensors, which can provide real-time data crucial for diagnosing and monitoring neurological conditions. The demand for sensors is expected to grow as the focus on precision medicine and personalized healthcare continues to rise. Sensors' capability to offer detailed and specific data makes them indispensable in the development of advanced brain monitoring devices, influencing the market by driving the need for high-quality, reliable sensors that can enhance diagnostic and monitoring accuracy.
Electrodes are another essential accessory in the brain monitoring market, primarily used in devices like EEGs for recording electrical activity in the brain. The design, material, and placement of electrodes significantly affect the quality of the data collected, impacting the diagnosis and treatment of neurological conditions. Innovations in electrode technology, such as the development of dry electrodes or wireless electrodes, aim to improve patient comfort, reduce setup time, and enhance signal quality. As the prevalence of neurological disorders increases and the demand for non-invasive monitoring solutions grows, the need for advanced electrodes that can provide accurate and reliable data while ensuring patient comfort is expected to influence the market positively.
Both sensors and electrodes are integral to the functionality of brain monitoring devices, directly impacting their effectiveness and efficiency. As the market for brain monitoring expands, driven by technological advancements and an increasing focus on neurological health, the development and refinement of these accessories will play a crucial role in shaping the future landscape of brain monitoring solutions. Their ongoing evolution is expected to support the market's growth by enhancing the capabilities of brain monitoring devices, thereby improving patient outcomes and expanding the applications of brain monitoring in healthcare.
Market Breakup by Procedures
The brain monitoring market report includes segmentation based on procedures. It is primarily divided into invasive and non-invasive categories. This segmentation reflects the varied approaches in monitoring brain activity and diagnosing neurological conditions, each with its distinct market impact and trajectory.
Invasive procedures involve techniques where sensors or devices are inserted into the body or brain to gather data. This method is typically employed for serious conditions requiring precise monitoring, such as in cases of severe traumatic brain injury, epilepsy surgery, and intracranial pressure monitoring. Despite their precision and specificity, invasive procedures are limited by higher risks and costs, which may constrain their widespread adoption. However, their indispensability in critical care and complex diagnostic situations ensures a continued demand within specific clinical settings.
Non-invasive brain monitoring, on the other hand, encompasses techniques that do not require any incision or insertion into the body. This category includes electroencephalography (EEG), functional MRI (fMRI), and transcranial Doppler, among others. The appeal of non-invasive methods lies in their lower risk, greater patient comfort, and the ability to perform repeated measurements over time without the complications associated with surgical interventions. The non-invasive segment is witnessing rapid brain monitoring market growth, driven by technological advancements that improve the accuracy, portability, and ease of use of these devices. This trend towards non-invasive monitoring is expected to dominate the market's direction in the forecast period, reflecting a broader shift towards safer, more patient-friendly diagnostic and monitoring solutions.
Market Breakup by End-user
On the basis of end users, the market is divided into hospitals, diagnostic centers, neurology centers, and others, each playing a vital role in the ecosystem of neurological care and diagnosis.
Hospitals, as primary healthcare providers, represent a significant brain monitoring market share. It can be attributed to their comprehensive care facilities, including emergency services, surgery, and intensive care units, where brain monitoring is crucial for various applications from trauma to critical care. The growing emphasis on neurological health and the increasing incidence of brain-related disorders have made brain monitoring an integral part of hospital care, driving demand for advanced monitoring equipment and technologies within this setting.
Diagnostic centers form another key segment, specializing in the detection and diagnosis of neurological conditions. With the advent of advanced imaging and monitoring technologies, these centers play a pivotal role in the early diagnosis and management of diseases, contributing to the overall growth of the brain monitoring market by facilitating access to specialized diagnostic services.
Neurology centers, dedicated to the treatment and study of neurological disorders, rely heavily on brain monitoring technologies for both diagnostic and therapeutic purposes. These centers are at the forefront of adopting the latest advancements in brain monitoring, driving innovation and utilization in clinical practices. Their focus on comprehensive neurological care, from diagnosis to treatment and rehabilitation, underscores their impact on the demand for specialized brain monitoring solutions.
In conclusion, the brain monitoring market segmentation by end-users highlights the diverse settings in which brain monitoring technologies are applied, each with its unique contributions to market dynamics. Hospitals, diagnostic centers, and neurology centers remain pivotal in driving the demand for advanced brain monitoring solutions. As the prevalence of neurological conditions continues to rise globally, the importance of effective brain monitoring across all these end-user segments is expected to grow, influencing market trends and opportunities in the forecast period.
Market Breakup by Region
The global brain monitoring market is segmented by region, reflecting varied market dynamics, healthcare infrastructure, and technological adoption rates across different geographies.
North America is a leading region in the market, characterized by advanced healthcare infrastructure, high healthcare expenditure, and a strong presence of leading market players. The region's commitment to research and development, coupled with quick adoption of innovative technologies, particularly in the United States and Canada, positions it as a hub for advanced brain monitoring solutions. The prevalence of neurological disorders and the emphasis on healthcare innovation are expected to continue driving the market's growth in this region.
Europe follows closely, with its sophisticated healthcare systems, stringent regulatory standards for medical devices, and a strong focus on patient care and safety. Countries like Germany, the UK, and France are at the forefront of adopting brain monitoring technologies, supported by government healthcare policies and a high awareness of neurological conditions. The region's focus on research and quality healthcare services is anticipated to sustain its significant impact on the global market.
Asia Pacific is identified as the region poised to experience significant brain monitoring market growth, likely to be driven by rapid economic development, increasing healthcare expenditure, and a growing population base. Countries such as China, Japan, and India are investing heavily in healthcare infrastructure and are increasingly open to adopting new technologies. The rising prevalence of neurological diseases and expanding healthcare access in this region offer a substantial growth opportunity for the brain monitoring market.
Latin America, despite being an emerging market, shows promise due to its improving healthcare infrastructure, growing awareness of neurological conditions, and increasing government and private investments in healthcare. Countries like Brazil and Mexico are leading this trend, with the market expected to gain momentum as access to healthcare services expands.
Middle East and Africa present a unique market with untapped potential, albeit with challenges related to healthcare infrastructure and access. However, increasing investments in healthcare, particularly in Gulf Cooperation Council (GCC) countries, and efforts to modernize healthcare facilities are expected to gradually enhance the adoption of brain monitoring technologies.
The brain monitoring market is characterized by the presence of several key players, each contributing to the market's growth with their innovative products, extensive research and development initiatives, and strategic market approaches. These players range from established multinational corporations to specialized medical device companies, all competing to enhance their market share and establish leadership in this highly competitive field.
The key features of the brain monitoring market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS | |
Base Year | 2023 | |
Historical Period | 2017-2023 | |
Forecast Period | 2024-2032 | |
Unit | USD billion | |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
|
Product Types Covered |
|
|
Applications Covered |
|
|
Modalities Covered |
|
|
Accessories Covered |
|
|
Procedures Covered |
|
|
End-users Covered |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Covered |
|
|
Customization Scope | 10% | |
Report Price and Purchase Option |
|
|
Post-Sale Analyst Support | 10 to 12 Weeks | |
Customization Scope | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Brain Monitoring Market Overview
3.1 Global Brain Monitoring Market Historical Value (2017-2023)
3.2 Global Brain Monitoring Market Forecast Value (2024-2032)
4 Global Brain Monitoring Market Landscape*
4.1 Global Brain Monitoring: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Brain Monitoring: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Applications
4.2.3 Analysis by Modality
4.2.4 Analysis by Accessories
4.2.5 Analysis by Procedures
5 Global Brain Monitoring Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Brain Monitoring Market Segmentation (2017-2032)
6.1 Global Brain Monitoring Market (2017-2032) by Product Types
6.1.1 Market Overview
6.1.2 Magnetoencephalograph (MEG)
6.1.3 Electroencephalograph Cerebral Oximeters
6.1.4 Functional Magnetic Resonance Imaging (fMRI)
6.1.5 Intracranial Pressure Monitoring Devices
6.1.6 Electroencephalogram (EEG)
6.1.7 Others
6.2 Global Brain Monitoring Market (2017-2032) by Applications
6.2.1 Market Overview
6.2.2 Parkinson’s Disease
6.2.3 Traumatic Brain Injury Epilepsy
6.2.4 Dementia
6.2.5 Sleep Disorders
6.2.6 Others
6.3 Global Brain Monitoring Market (2017-2032) by Modality
6.3.1 Market Overview
6.3.2 Fixed
6.3.3 Portable
6.3.4 Wearable
6.4 Global Brain Monitoring Market (2017-2032) by Accessories
6.4.1 Market Overview
6.4.2 Sensor
6.4.3 Electrode
6.5 Global Brain Monitoring Market (2017-2032) by Procedures
6.5.1 Market Overview
6.5.2 Invasive
6.5.3 Non-invasive
6.6 Global Brain Monitoring Market (2017-2032) by End User
6.6.1 Market Overview
6.6.2 Hospitals
6.6.3 Diagnostic Centers
6.6.4 Neurology Centers
6.6.5 Others
6.7 Global Brain Monitoring Market (2017-2032) by Region
6.7.1 Market Overview
6.7.2 North America
6.7.3 Europe
6.7.4 Asia Pacific
6.7.5 Latin America
6.7.6 Middle East and Africa
7 North America Brain Monitoring Market (2017-2032)
7.1 North America Brain Monitoring Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Magnetoencephalograph (MEG)
7.1.3 Electroencephalograph Cerebral Oximeters
7.1.4 Functional Magnetic Resonance Imaging (FMRI)
7.1.5 Intracranial pressure Monitoring Devices
7.1.6 electroencephalogram (EEG)
7.1.7 Others
7.2 North America Brain Monitoring Market (2017-2032) by Applications
7.2.1 Market Overview
7.2.2 Parkinson’s Disease
7.2.3 Traumatic Brain Injury Epilepsy
7.2.4 Dementia
7.2.5 Sleep Disorders
7.2.6 Others
7.3 North America Brain Monitoring Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Brain Monitoring Market (2017-2032)
8.1 Europe Brain Monitoring Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Magnetoencephalograph (MEG)
8.1.3 Electroencephalograph Cerebral Oximeters
8.1.4 Functional Magnetic Resonance Imaging (FMRI)
8.1.5 Intracranial pressure Monitoring Devices
8.1.6 electroencephalogram (EEG)
8.1.7 Others
8.2 Europe Brain Monitoring Market (2017-2032) by Applications
8.2.1 Market Overview
8.2.2 Parkinson’s Disease
8.2.3 Traumatic Brain Injury Epilepsy
8.2.4 Dementia
8.2.5 Sleep Disorders
8.2.6 Others
8.3 Europe Brain Monitoring Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Brain Monitoring Market (2017-2032)
9.1 Asia Pacific Brain Monitoring Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Magnetoencephalograph (MEG)
9.1.3 Electroencephalograph Cerebral Oximeters
9.1.4 Functional Magnetic Resonance Imaging (FMRI)
9.1.5 Intracranial pressure Monitoring Devices
9.1.6 electroencephalogram (EEG)
9.1.7 Others
9.2 Asia Pacific Brain Monitoring Market (2017-2032) by Applications
9.2.1 Market Overview
9.2.2 Parkinson’s Disease
9.2.3 Traumatic Brain Injury Epilepsy
9.2.4 Dementia
9.2.5 Sleep Disorders
9.2.6 Others
9.3 Asia Pacific Brain Monitoring Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Others
10 Latin America Brain Monitoring Market (2017-2032)
10.1 Latin America Brain Monitoring Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Magnetoencephalograph (MEG)
10.1.3 Electroencephalograph Cerebral Oximeters
10.1.4 Functional Magnetic Resonance Imaging (FMRI)
10.1.5 Intracranial pressure Monitoring Devices
10.1.6 electroencephalogram (EEG)
10.1.7 Others
10.2 Latin America Brain Monitoring Market (2017-2032) by Applications
10.2.1 Market Overview
10.2.2 Parkinson’s Disease
10.2.3 Traumatic Brain Injury Epilepsy
10.2.4 Dementia
10.2.5 Sleep Disorders
10.2.6 Others
10.3 Latin America Brain Monitoring Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Brain Monitoring Market (2017-2032)
11.1 Middle East and Africa Brain Monitoring Market (2017-2032) by Product
11.1.1 Market Overview
11.1.2 Magnetoencephalograph (MEG)
11.1.3 Electroencephalograph Cerebral Oximeters
11.1.4 Functional Magnetic Resonance Imaging (FMRI)
11.1.5 Intracranial pressure Monitoring Devices
11.1.6 electroencephalogram (EEG)
11.1.7 Others
11.2 Middle East and Africa Brain Monitoring Market (2017-2032) by Applications
11.2.1 Market Overview
11.2.2 Parkinson’s Disease
11.2.3 Traumatic Brain Injury Epilepsy
11.2.4 Dementia
11.2.5 Sleep Disorders
11.2.6 Others
11.3 Middle East and Africa Brain Monitoring Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Medtronic
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 GE HealthCare
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Integra LifeSciences Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Nihon kohden corporation
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Masimo Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Natus Medical corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Siemens Healthcare Private Limited
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Advanced Brain Monitoring, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Koninklijke Philips N.V.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Compumedics Limited
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 BrainScope Company Inc
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Cadwell Industries, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
List not exhaustive
18 Global Brain Monitoring Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.